is tirzepatide a glp-1 agonist Tirzepatide, dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology GLP-1 Receptor Agonists - Mechanisms
Description
Br J Clin Pharmacol (2018) 84(10):232535
This pattern continued when assessing the risk for atrial fibrillation, as the GLP-1 group had a significantly decreased risk for this outcome vs
Acute pancreatitis and thyroid-related adverse events have been reported, and attention should be paid during use
Figure 1 shows the average likelihood rating for each food system player across participants with and without GLP-1 medication experience
doi: 10.1186/1471-2458-9-88 21 YounossiZM
doi: 10.1155/2007/76396 191 TaliazD.StallN.DarD
